Quantitative characterization of the mechanism of action and impact of a 'proteolysis-permitting' anti-PCSK9 antibody.

about

Quantitative characterization of the mechanism of action and impact of a 'proteolysis-permitting' anti-PCSK9 antibody.

Item

http://www.wikidata.org/entity/Q42323238

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Quantitative characterization ...... rmitting' anti-PCSK9 antibody.

@en

Quantitative characterization ...... rmitting' anti-PCSK9 antibody.

@nl

type

Item

label

Quantitative characterization ...... rmitting' anti-PCSK9 antibody.

@en

Quantitative characterization ...... rmitting' anti-PCSK9 antibody.

@nl

prefLabel

Quantitative characterization ...... rmitting' anti-PCSK9 antibody.

@en

Quantitative characterization ...... rmitting' anti-PCSK9 antibody.

@nl

P1476

Quantitative characterization ...... rmitting' anti-PCSK9 antibody.

@en

P2093

Andrea E Sperry

http://www.w3.org/2001/XMLSchema#string

Krista M Schroeder

http://www.w3.org/2001/XMLSchema#string

Michael J Berna

http://www.w3.org/2001/XMLSchema#string

Patrick I Eacho

http://www.w3.org/2001/XMLSchema#string

Ryan J Hansen

http://www.w3.org/2001/XMLSchema#string

Thomas P Beyer

http://www.w3.org/2001/XMLSchema#string

Victor J Wroblewski

http://www.w3.org/2001/XMLSchema#string

P2860

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia

PCSK9 inhibitors in the prevention of cardiovascular disease

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor.

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

Comparison of four basic models of indirect pharmacodynamic responses

A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

P304

285-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19420862.2016.1270490

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27981884

http://www.w3.org/2001/XMLSchema#string

P921

proteolysis

P932

5297531

http://www.w3.org/2001/XMLSchema#string